Negative Pressure Wound Therapy (NPWT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Negative Pressure Wound Therapy (NPWT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Negative Pressure Wound Therapy (NPWT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Negative Pressure Wound Therapy (NPWT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Negative Pressure Wound Therapy (NPWT) is used to treat acute and chronic wounds. A vacuum source from the NPWT device creates continuous or intermittent negative pressure inside the wound to remove fluid, exudates, and infectious materials to which helps in healing and closure.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Negative Pressure Wound Therapy (NPWT) Overview
Products under Development
Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Table Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Stage of Development
Negative Pressure Wound Therapy (NPWT) - Pipeline Products by Segment
Table Otivio AS - Ongoing Clinical Trials Overview
Table FlowOx 2.0 - Multiple Sclerosis - A Double-blind, Randomized, Controlled, Parallel Design 4-week Investigation, Followed by an Open 6-month Investigation, to Evaluate the Performance and Long-term Safety of FlowOx2.0 in Patients with Multiple Sclerosis
Table FlowOx 2.0 - Multiple Sclerosis - An Open 6-month Investigation, to Evaluate the Performance and Long-term Safety of FlowOx2.0 in Subjects with Multiple Sclerosis
Progenerative Medical Inc Company Overview
Progenerative Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Progenerative Medical Inc - Ongoing Clinical Trials Overview
Table Regenn Therapy Device - A Randomized Clinical Study Evaluating the Safety of Regenn Negative Pressure Therapy System in Orthopaedic Surgical Wound Management
Table Wake Forest Baptist Medical Center - Ongoing Clinical Trials Overview
Table Mechanical Tissue Resuscitation Device - A Multi-center, Early Feasibility Study of Using the Mechanical Tissue Resuscitation (MTR) Therapy System for Removal of Excess Fluid in Subjects Who Have Had a Portion of Their Skull Removed to Expose the Dura/Brain and Require Drainage for Fluid Removal.
Worldwide Innovative Healthcare, Inc. Company Overview
Aug 06, 2024: InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems
Aug 05, 2024: Nexa Medical Receives Additional 510(K) Clearance For Nexa Negative Pressure Wound Therapy System
Jul 29, 2024: Aoti Announces US FDA 510(K) Clearance of Nexa NPWT System for Use in the Home Care Setting
Jun 10, 2024: KCI USA Receives 510(K) Clearance For D 3M ActiV.A.C. Canister With Gel
Jun 06, 2024: Smith & Nephew Medical Receives Additional 510(K) Clearance For Renasys Edge (66803126)
Jun 03, 2024: Aatru Medical Awarded 1st Place in "Oral Abstracts" at SAWC Spring 2024 Symposium
Apr 30, 2024: DeRoyal Industries Receives 510(K) Clearance For Prospera Spectruum Negative Pressure Wound Therapy System
Apr 30, 2024: Carilex Medical Receives 510(K) Clearance For Carilex VT 200-i NX
Apr 09, 2024: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for use in the United States
Apr 04, 2024: Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
Apr 02, 2024: Smith+Nephew launches wound therapy system in US
Mar 12, 2024: ExtriCARE USA Introduces the ExtriCARE 1000 NPWT System
Mar 11, 2024: Guard Medical Receives Additional 510(K) Clearance For NPseal Negative Pressure Advanced System
Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
Feb 17, 2024: Clear Choice Therapeutics Receives 510(K) Clearance For PREVENT Kit
Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting
Jan 25, 2024: Clinical Evidence From Enivo Pilot Study Paves the Way for Potentially New Therapy
Dec 24, 2023: Cork Medical Products Receives 510(k) Clearance for VERSA Negative Pressure Wound System (VCMPP-100)
Dec 05, 2023: Argentum Medical Announces Plans to Expand the Company's Presence in Saudi Arabia
Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Aug 15, 2023: Medela Expands Negative Pressure Wound Therapy Product Solutions With New Integrated Dressing
Aug 15, 2023: Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2023 at High End of Investor Day Guidance